| Literature DB >> 32636674 |
Edgar Villegas-Hinojosa1, Yolanda Terán-Figueroa1, Veronica Gallegos-García1, Dario Gaytán-Hernández1, Sandra O Gutiérrez-Enríquez1, Anahid E Campuzano-Barajas2, Luz E Alcántara-Quintana3.
Abstract
AIM: Cervical cancer (CC) is considered as a major public health problem; this disease affects mainly vulnerable women in poverty, causing a negative effect on a country's workforce.Entities:
Keywords: CIN; HSIL; LSIL; cervical cancer; cervical intraepithelial neoplasia; high-grade squamous intraepithelial lesion; histopathological diagnosis; levels; low-grade squamous intraepithelial lesion
Year: 2020 PMID: 32636674 PMCID: PMC7326688 DOI: 10.2147/CMAR.S225067
Source DB: PubMed Journal: Cancer Manag Res ISSN: 1179-1322 Impact factor: 3.989
Figure 1Block of paraffin and cuts at different levels. The lines and numbers mark the cut levels from the first to the fourth. The cuts were made before reaching each line. The continuous line shows the first level; this is where the first cut was made by the original institution pathologist and represents the sample with which the initial diagnosis was established. The dotted lines show the second to the third levels. The numbers mark the sites where slabs and cuts were made to reassess the initial diagnosis.
Figure 2Main changes and results based on the examination of the different levels of the paraffin blocks. a is the group change of diagnosis, 36.8%; b is the poorly oriented 12.5%, and c is the biopsy ends, 7.6%. The groups a, b and c had statistical differences p ≤ 0.05.
Figure 3Change from the initial diagnosis based on evaluation of the second level of the paraffin block (value of p ≤ 0.05). n=120.
Figure 4Change from the initial diagnosis based on evaluation of the third level of the paraffin block (value of p ≤ 0.05). n=120.
Figure 5Change from the initial diagnosis based on evaluation of the fourth level of the paraffin block (value of p ≤ 0.05). n=120.
Concordance of Histopathological Diagnoses (p ≤ 0.05). n=120 Direct Source
| Diagnosis 2 | ||||||||
|---|---|---|---|---|---|---|---|---|
| HPV | CIN I | CIN II | CIN III | Cancer in situ | Invasive Cancer | Total | ||
| Diagnosis 1 | HPV I | 16 | 2 | 0 | 0 | 0 | 0 | 18 |
| CIN I | 13 | 33 | 4 | 0 | 0 | 0 | 50 | |
| CIN II | 0 | 8 | 6 | 4 | 1 | 0 | 19 | |
| CIN III | 0 | 2 | 2 | 25 | 1 | 0 | 30 | |
| Cancer in situ | 0 | 0 | 0 | 0 | 15 | 3 | 18 | |
| Invasive Cancer | 0 | 0 | 0 | 0 | 0 | 17 | 17 | |
| 29 | 45 | 12 | 29 | 17 | 20 | 152 | ||